BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35445736)

  • 21. CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.
    Hu J; Shen J; Sun J
    Biomed Pharmacother; 2020 May; 125():109870. PubMed ID: 32032891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15.
    Khan AA; Huang H; Zhao Y; Li H; Pan R; Wang S; Liu X
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35088887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
    Ma J; Yang D; Ma XX
    Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.
    Kong X; Li M; Shao K; Yang Y; Wang Q; Cai M
    Oncol Rep; 2020 Jan; 43(1):121-132. PubMed ID: 31746409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ISG15 in cancer: Beyond ubiquitin-like protein.
    Han HG; Moon HW; Jeon YJ
    Cancer Lett; 2018 Dec; 438():52-62. PubMed ID: 30213559
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Xu H; Sun Y; Ma Z; Xu X; Qin L; Luo B
    Aging (Albany NY); 2018 Nov; 10(11):3353-3370. PubMed ID: 30485833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
    Le L; Luo J; Wu H; Chen L; Tang X; Fu F
    Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.
    Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X
    BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
    Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
    Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
    Li L; Qu YW; Li YP
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ISG15 deficiency and increased viral resistance in humans but not mice.
    Speer SD; Li Z; Buta S; Payelle-Brogard B; Qian L; Vigant F; Rubino E; Gardner TJ; Wedeking T; Hermann M; Duehr J; Sanal O; Tezcan I; Mansouri N; Tabarsi P; Mansouri D; Francois-Newton V; Daussy CF; Rodriguez MR; Lenschow DJ; Freiberg AN; Tortorella D; Piehler J; Lee B; García-Sastre A; Pellegrini S; Bogunovic D
    Nat Commun; 2016 May; 7():11496. PubMed ID: 27193971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
    Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
    Yang L; Cui Y; Sun X; Wang Y
    Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of interferon-stimulated gene 15 and its conjugation machinery, UbE1L and UbcH8 expression by tumor necrosis factor-α through p38 MAPK and JNK signaling pathways in human lung carcinoma.
    Lertsooksawat W; Wongnoppavich A; Chairatvit K
    Mol Cell Biochem; 2019 Dec; 462(1-2):51-59. PubMed ID: 31428903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
    Burks J; Reed RE; Desai SD
    Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
    Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
    J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.
    Gómez CE; Perdiguero B; Falqui M; Marín MQ; Bécares M; Sorzano CÓS; García-Arriaza J; Esteban M; Guerra S
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.